KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cigna (CI) Shares Outstanding (2018 - 2025)

Cigna (CI) has disclosed Shares Outstanding for 8 consecutive years, with $404.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.4% to $404.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $404.6 million through Dec 2025, changed 0.4% year-over-year, with the annual reading at $404.6 million for FY2025, 0.4% changed from the prior year.
  • Shares Outstanding hit $404.6 million in Q4 2025 for Cigna, roughly flat from $404.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $404.6 million in Q4 2025 to a low of $298.7 million in Q4 2022.
  • Historically, Shares Outstanding has averaged $390.8 million across 5 years, with a median of $399.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding: fell 8.97% in 2021 and later soared 33.89% in 2023.
  • Year by year, Shares Outstanding stood at $322.9 million in 2021, then decreased by 7.52% to $298.7 million in 2022, then soared by 33.89% to $399.9 million in 2023, then increased by 0.78% to $403.0 million in 2024, then grew by 0.4% to $404.6 million in 2025.
  • Business Quant data shows Shares Outstanding for CI at $404.6 million in Q4 2025, $404.0 million in Q3 2025, and $404.0 million in Q2 2025.